LCCC 1335: A Single-Arm Phase I/II Clinical Trial of Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma in Malawi
Phase of Trial: Phase I/II
Latest Information Update: 05 May 2017
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 20 Jul 2016 New trial record
- 13 Jul 2016 Status changed from not yet recruiting to recruiting.
- 13 Jul 2016 Planned primary completion date changed from 1 Dec 2021 to 1 Mar 2021.